https://www.selleckchem.com/pr....oducts/tetramisole-h
Mean age was 12.3 ± 5.1 years, weight was 53.8 ± 28.9 kg, and median Pediatric Risk of Mortality II was 7 (range 2-19). Circuit iCa levels were maintained at0.40 mmol/l for 90.2% of the SCD therapy time. Median SCD duration was 6 days. Fifteen subjects survived SCD therapy; 12 survived to ICU discharge. All ICU survivors were dialysis independent at 60 days. No SCD-related adverse events (AEs) were reported. Our data demonstrate that SCD therapy is feasible and safe in children who require CKRT. Although we cannot make effic
Like
Comment
Share
